Yahoo Finance

Psytech To Merge With Wesana; Mycotopia Shareholders Will Benefit From The Transactions

MIAMI, July 14, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies, Inc., (OTC Pink: TPIA) ("Mycotopia" or the “Company”) announced today that on July 13, 2021 Wesana Health Holdings Inc. (“Wesana”) (CSE: ...
Yahoo Finance

Cube Psytech Signs Letter of Intent to Acquire Translational Life Sciences and Announces Private Placement

VANCOUVER, BC / ACCESSWIRE / February 10, 2023 / Cube Psytech Holdings Inc. (the "Company" or "CUBE"), a biopharmaceutical and biotechnology company focused on the research and development of ...
Benzinga.com

Beckley Psytech Doses First Patients With Psilocin In Trial For Treatment Of Major Depression Disorder

The UK-based psychedelics medicine company Beckley Psytech announced Thursday that it has dosed its first patients in a Phase IIa study (NCT05434156) of ELE-101, a patent-protected synthetic ...
Business Wire

Beckley Psytech Announces First Cohort of Psychotherapists Have Begun Training for Treatment Resistant Depression Phase 2 Trials

Training programme to be conducted in partnership with industry-leading educational company, Fluence Initiation of training represents key step to incorporate psychedelic-assisted psychotherapy to ...
Business Wire

First Patient Dosed in Beckley Psytech’s International Phase IIb Study of BPL-003, a Novel Synthetic Intranasal Formulation of 5-MeO-DMT, for Treatment Resistant Depression (TRD)

OXFORD, England--(BUSINESS WIRE)--Beckley Psytech Ltd, a private, clinical-stage biotechnology company developing rapid-acting, short-duration psychedelic medicines for neuropsychiatric conditions, ...
Business Insider

See the pitch deck a psychedelics startup just used to raise $18.6 million to develop new treatments derived from the Sonoran Desert toad

UK-based psychedelics company Beckley Psytech just closed an $18.6 million funding round, backed by investment firms Noetic Psychedelic Fund and Bail Capital. Beckley Psytech's upcoming clinical ...
The Business Journals

Wesana, led by former Blackhawks player, to acquire psychedelic therapy firm

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Wesana, a Chicago company led by former Blackhawks player ...
PharmiWeb

Beckley Psytech announces dosing of first healthy volunteers in Phase 1 clinical trial assessing safety and pharmacokinetics of second innovative formulation of 5-MeO-DMT

Study represents continued efforts to further understand the clinical and pharmacological potential of 5-MeO-DMT BPL-003 is Beckley Psytech’s innovative dry powder intranasal formulation of 5-MeO-DMT ...
manilatimes

Beckley Psytech announces positive topline data from Part 2 of its Phase IIa study of BPL-003 (intranasal 5-MeO-DMT benzoate) in combination with SSRIs for treatment resistant ...

Positive results show that a single dose of BPL-003, administered adjunctively to SSRIs, produced a rapid and long-lasting antidepressant effect for up to three months after dosing. BPL-003 was ...
pharmaphorum

Beckley Psytech raises $80m for psychedelic meds development

UK psychedelic medicine specialist Beckley Psytech has raised an impressive £58 million (around $80 million) in an oversubscribed second-round financing that will help fund clinical development of its ...
Anadolu Ajansi

Psytech International Sues Ex-employees, Alleges They Conspired to Steal Its Software and Customers

LONDON--(BUSINESS WIRE)-- Psytech International (“Psytech”), a leading worldwide provider of psychometric testing and workplace software for employers, announces that it is seeking to enforce its ...